A new drug targeting a hormone linked to hypertension has shown encouraging results in patients with chronic kidney disease. A drug that showed early signs of protecting damaged kidneys has now received FDA approval for treating high blood pressure that remains uncontrolled despite medication. Called Baxfendy (baxdrostat), the treatment targets a hormone involved in both […]
Fox Style News Syndicate. Sourced from broadcast reporting: Read Full Source Coverage.